Insider Trading & Executive Data
Start Free Trial
0 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
Lakeside Holding Ltd is an asset‑light, U.S.-based, Asian‑American‑owned integrated cross‑border logistics provider focused on trans‑Pacific trade (especially China and South Korea) into the U.S., offering ocean/air freight forwarding (NVOCC/indirect air carrier), customs clearance via partners, warehousing/distribution and U.S. domestic ground transportation. The business combines a proprietary cloud logistics platform and warehouse management system with a broad carrier and domestic carrier/driver network and operates regional warehouses in Illinois and Texas; in late 2024 it added a pharmaceutical distribution arm via the Hupan acquisition. For the year ended June 30, 2025 revenue was $17.79M (down 2.9%), gross profit compressed and the company reported a net loss of $5.25M amid higher G&A related to public‑company costs, while cash and financing activity (IPO/private placements, convertible debt, warrants) materially funded operations. Operations are seasonal (Q4 strongest) and highly dependent on carrier capacity, customs/regulatory licenses, and data/privacy controls — all material risk factors for near‑term performance.
Given Lakeside’s small, public‑company profile and recent loss, executive pay is likely tilted toward equity and long‑term incentives (stock, options, warrants) to conserve cash while aligning management with growth and margin recovery; the filing’s discussion of warrant classification and convertible instruments suggests executives may hold warrants or participate in financing rounds. Short‑term cash compensation and any annual bonuses are likely tied to revenue growth, freight gross margin improvement, EBITDA/adjusted operating income, cash‑flow or liquidity targets, and successful integration/performance of the new pharmaceutical segment (margin and working‑capital metrics). Additional award metrics may include regulatory/license compliance (FMC, TSA, customs), customer retention/volume targets and technology platform KPIs (order throughput, utilization of warehousing capacity) because these directly affect margin and service continuity. Expect heightened use of retention awards or change‑in‑control protections to retain a 94‑person team and to attract logistics/tech talent post‑IPO; full valuation allowance on deferred tax assets and public‑company cost pressures can keep cash salaries constrained.
Insider activity can be driven by participation in the company’s financings (private placements, convertible notes and warrants) as well as ordinary open‑market transactions; purchases or participation by insiders in financings signal confidence, while timely open‑market sales following warrant conversions or IPO-related vesting may indicate liquidity needs or hedging. Be alert for trading around macro and regulatory catalysts that materially affect trans‑Pacific volumes — U.S. tariff announcements, customs policy changes (e.g., de‑minimis rule), carrier capacity shifts, quarter‑end seasonality (Q4), and pharma‑regulatory or supplier disclosures — all can produce material information gaps. Low market float/liquidity magnifies price impact of insider sales or buys; monitoring 10b5‑1 plans, disclosure of warrant conversions, dilution from financing rounds, and blackout periods around earnings, license renewals or acquisitions is especially important for timing and signaling.